Relay Therapeutics, Inc.
RLAY
$12.47
-$0.31-2.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.20% | 18.13% | 13.79% | 3.49% | -1.30% |
| Total Depreciation and Amortization | -45.94% | -34.90% | -22.03% | -10.73% | -3.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.21% | -11.30% | -4.22% | 5.00% | -10.39% |
| Change in Net Operating Assets | 143.78% | -259.41% | -156.30% | 18.80% | 73.54% |
| Cash from Operations | 21.56% | 5.48% | 11.40% | 6.88% | 4.06% |
| Capital Expenditure | 95.82% | 79.68% | 80.85% | 74.51% | 84.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,249.18% | 594.58% | 2,358.90% | -88.88% | -104.33% |
| Cash from Investing | 2,102.79% | 569.29% | 1,891.16% | -89.07% | -104.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -36.54% | -99.41% | -99.50% | 169.24% | 168.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -36.54% | -99.41% | -99.50% | 169.24% | 168.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 284.04% | -104.88% | -13,853.74% | -75.20% | -623.57% |